Related Experiment Video
Updated: May 2, 2026
08:35
Elastomeric PGS Scaffolds in Arterial Tissue Engineering
Published on: April 8, 2011
18.0K
Bioresorbable scaffolds in peripheral arterial disease
George Kassimis1, Stavros Spiliopoulos, Konstantinos Katsanos
1Oxford Heart Centre, Oxford University Hospitals NHS Trust, Oxford, UK.
Expert Review of Cardiovascular Therapy
|March 22, 2014
Summary
Bioresorbable scaffolds (BRS) offer a promising alternative to permanent stents for peripheral arterial disease. These devices provide temporary support and drug elution, eventually being absorbed by the body.
Area of Science:
- Biomaterials Science
- Cardiovascular Research
- Medical Device Technology
Background:
- Permanent endovascular devices like drug-eluting stents reduce restenosis but can cause long-term complications.
- Stent thrombosis and restenosis remain challenges in peripheral arterial interventions.
Purpose of the Study:
- To review advancements in bioresorbable scaffold (BRS) technology for peripheral arterial disease.
- To explain the resorption mechanisms of BRS.
- To discuss the current and future applications of BRS.
Main Methods:
- Review of current literature on bioresorbable scaffolds.
- Analysis of BRS technologies in clinical trials and preclinical settings.
- Discussion of resorption processes and anti-restenotic drug elution.
Main Results:
- Bioresorbable scaffolds provide mechanical support and targeted drug delivery.
- Scaffolds are designed to be fully absorbed into the vascular wall over time.
- Several BRS technologies are currently under evaluation.
Conclusions:
- Bioresorbable scaffolds represent an innovative treatment option for peripheral arterial disease.
- The development of BRS aims to overcome limitations associated with permanent stents.
- Further research and clinical evaluation are ongoing for BRS.
